A safer hypoglycemic agent for type 2 diabetes—Berberine organic acid salt
- 1 November 2017
- journal article
- Published by Elsevier BV in Journal of Functional Foods
- Vol. 38, 399-408
- https://doi.org/10.1016/j.jff.2017.09.031
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (81503206)
This publication has 52 references indexed in Scilit:
- Novel role of the nutraceutical bioactive compound berberine in lectin-like OxLDL receptor 1-mediated endothelial dysfunction in comparison to lovastatinNutrition, Metabolism and Cardiovascular Diseases, 2017
- Non-coding RNAs and Berberine: A new mechanism of its anti-diabetic activitiesEuropean Journal of Pharmacology, 2017
- Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studiesBiochemistry and Cell Biology, 2015
- Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a∼125b cluster function by seed-targeting inhibitors in multiple myeloma cellsRNA Biology, 2015
- Potential Benefits of Berberine in the Management of Perimenopausal SyndromeOxidative Medicine and Cellular Longevity, 2015
- Incidence, Nature, and Etiology of Metabolic Alkalosis in Dogs and CatsJournal of Veterinary Internal Medicine, 2013
- Deciphering the mechanisms of the Na+/H+exchanger-3 regulation in organ dysfunctionAmerican Journal of Physiology-Cell Physiology, 2012
- TASK channels are not required to mount an aldosterone secretory response to metabolic acidosis in miceMolecular and Cellular Endocrinology, 2011
- Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patientsCritical Care, 2006
- Prolonging Viability of Swine Muscle Biopsy Specimens in Malignant Hyperthermia TestingAnesthesia & Analgesia, 2001